Aliases & Classifications for Dementia

MalaCards integrated aliases for Dementia:

Name: Dementia 12 51 29 52 41 3 14 69
Presenile Dementia 69

Classifications:



External Ids:

Disease Ontology 12 DOID:1307
ICD9CM 35 290.8
UMLS 69 C0154319

Summaries for Dementia

NINDS : 51 Dementia is not a specific disease. It is a descriptive term for a collection of symptoms that can be caused by a number of disorders that affect the brain. People with dementia have significantly impaired intellectual functioning that interferes with normal activities and relationships. They also lose their ability to solve problems and maintain emotional control, and they may experience personality changes and behavioral problems, such as agitation, delusions, and hallucinations. While memory loss is a common symptom of dementia, memory loss by itself does not mean that a person has dementia. Doctors diagnose dementia only if two or more brain functions - such as memory and language skills -- are significantly impaired without loss of consciousness.  Some of the diseases that can cause symptoms of dementia are Alzheimer’s disease, vascular dementia, Lewy body dementia, frontotemporal dementia, Huntington’s disease, and Creutzfeldt-Jakob disease.  Doctors have identified other conditions that can cause dementia or dementia-like symptoms including reactions to medications, metabolic problems and endocrine abnormalities, nutritional deficiencies, infections, poisoning, brain tumors, anoxia or hypoxia (conditions in which the brain’s oxygen supply is either reduced or cut off entirely), and heart and lung problems.  Although it is common in very elderly individuals, dementia is not a normal part of the aging process.

MalaCards based summary : Dementia, also known as presenile dementia, is related to vascular dementia and dementia, frontotemporal, and has symptoms including angina pectoris, back pain and headache. An important gene associated with Dementia is PSEN1 (Presenilin 1). The drugs Dopamine and Memantine have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and heart.

Disease Ontology : 12 A cognitive disorder resulting from a loss of brain function affecting memory, thinking, language, judgement and behavior.

MedlinePlus : 41 dementia is the name for a group of symptoms caused by disorders that affect the brain. it is not a specific disease. people with dementia may not be able to think well enough to do normal activities, such as getting dressed or eating. they may lose their ability to solve problems or control their emotions. their personalities may change. they may become agitated or see things that are not there. memory loss is a common symptom of dementia. however, memory loss by itself does not mean you have dementia. people with dementia have serious problems with two or more brain functions, such as memory and language. although dementia is common in very elderly people, it is not part of normal aging. many different diseases can cause dementia, including alzheimer's disease and stroke. drugs are available to treat some of these diseases. while these drugs cannot cure dementia or repair brain damage, they may improve symptoms or slow down the disease. nih: national institute of neurological disorders and stroke

CDC : 3 The role of public health in enhancing the physical health of older adults is well-known. Public health’s role in maintaining cognitive health, a vital part of healthy aging and quality of life, is emerging. The need for a clearly delineated public health role comes at a critical time given the dramatic aging of the U.S. population, scientific advancements in knowledge about risk behaviors (e.g., lack of physical activity, uncontrolled high blood pressure) related to cognitive decline, and the growing awareness of the significant health, social, and economic burdens associated with cognitive decline. The Healthy Brain Initiative is a multifaceted approach to cognitive health with several components, including:

Wikipedia : 72 Dementia is a broad category of brain diseases that cause a long term and often gradual decrease in the... more...

Related Diseases for Dementia

Diseases related to Dementia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 513)
id Related Disease Score Top Affiliating Genes
1 vascular dementia 12.3
2 dementia, frontotemporal 12.3
3 dementia, lewy body 12.3
4 amyotrophic lateral sclerosis-parkinsonism/dementia complex 12.1
5 semantic dementia 12.1
6 dementia pugilistica 12.1
7 frontotemporal dementia and/or amyotrophic lateral sclerosis 1 12.1
8 grn-related frontotemporal dementia 12.1
9 dementia, familial, nonspecific 12.1
10 inclusion body myopathy with paget disease of bone and frontotemporal dementia 12.0
11 dementia, familial danish 12.0
12 inclusion body myopathy with early-onset paget disease and frontotemporal dementia 12.0
13 frontotemporal dementia and/or amyotrophic lateral sclerosis 2 12.0
14 frontotemporal dementia and/or amyotrophic lateral sclerosis 4 12.0
15 dementia - subcortical 12.0
16 frontotemporal dementia and/or amyotrophic lateral sclerosis 3 12.0
17 inclusion body myopathy with early-onset paget disease and frontotemporal dementia 1 12.0
18 amyotrophic lateral sclerosis 14, with or without frontotemporal dementia 12.0
19 alzheimer disease 11.9
20 amyotrophic lateral sclerosis 15, with or without frontotemporal dementia 11.9
21 inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 11.9
22 inclusion body myopathy with early-onset paget disease without frontotemporal dementia 3 11.9
23 frontotemporal dementia with parkinsonism-17 11.9
24 amyotrophic lateral sclerosis 22 with or without frontotemporal dementia 11.9
25 amyotrophic lateral sclerosis 6, with or without frontotemporal dementia 11.9
26 juvenile amyotrophic lateral sclerosis with dementia 11.9
27 aids dementia complex 11.8
28 dementia, familial british 11.8
29 binswanger's disease 11.8
30 pick disease 11.8
31 c9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia 11.8
32 dnmt1-related dementia, deafness, and sensory neuropathy 11.8
33 behavioral variant of frontotemporal dementia 11.8
34 nasu-hakola disease 11.7
35 chorea and dementia 11.7
36 cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1 11.7
37 ubqln2-related amyotrophic lateral sclerosis/frontotemporal dementia 11.6
38 vcp-related amyotrophic lateral sclerosis/frontotemporal dementia 11.6
39 tardbp-related frontotemporal dementia 11.6
40 presenile dementia, kraepelin type 11.6
41 prkar1b-related neurodegenerative dementia with intermediate filaments 11.6
42 parkinsonism with dementia of guadeloupe 11.6
43 dementia with epilepsy, mapt-related 11.6
44 frontotemporal lobar degeneration with ubiquitin-positive inclusions 11.5
45 amyotrophic lateral sclerosis 1 11.5
46 supranuclear palsy, progressive atypical 11.5
47 creutzfeldt-jakob disease 11.5
48 mohr-tranebjaerg syndrome 11.4
49 neuropathy, hereditary sensory, type ie 11.4
50 gerstmann-straussler disease 11.4

Graphical network of the top 20 diseases related to Dementia:



Diseases related to Dementia

Symptoms & Phenotypes for Dementia

UMLS symptoms related to Dementia:


angina pectoris, back pain, headache, pain, sciatica, seizures, syncope, tremor, chronic pain, vertigo/dizziness, equilibration disorder, sleeplessness

Drugs & Therapeutics for Dementia

Drugs for Dementia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 828)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
2
Memantine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 19982-08-2 4054
3
Levodopa Approved Phase 4,Phase 2,Phase 3,Phase 1 59-92-7 6047
4
Citalopram Approved Phase 4,Phase 3,Phase 2,Phase 1 59729-33-8 2771
5
Methylphenidate Approved, Investigational Phase 4,Phase 3,Phase 2 113-45-1 4158
6
Galantamine Approved Phase 4,Phase 3,Phase 2,Phase 1 357-70-0 9651
7
Risperidone Approved, Investigational Phase 4,Phase 3,Phase 2 106266-06-2 5073
8
Donepezil Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 120014-06-4 3152
9
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1994-09-7, 94-09-7 2337
10
Rivastigmine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 123441-03-2 77991
11
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-28-2 5757
12
Medroxyprogesterone acetate Approved, Investigational Phase 4,Phase 2,Phase 3 71-58-9
13
Progesterone Approved, Vet_approved Phase 4,Phase 2,Phase 3 57-83-0 5994
14
Menthol Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 2216-51-5 16666
15
Nimodipine Approved Phase 4,Phase 1 66085-59-4 4497
16
Rasagiline Approved Phase 4,Phase 2 136236-51-6 3052776
17
Cilostazol Approved Phase 4,Phase 2 73963-72-1 2754
18
Guaifenesin Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 93-14-1 3516
19
Hydroxocobalamin Approved Phase 4,Phase 3,Phase 2 13422-51-0 11953898 5460373 44475014
20
Armodafinil Approved, Investigational Phase 4,Phase 3,Phase 2 112111-43-0
21
Modafinil Approved, Investigational Phase 4,Phase 3,Phase 2 68693-11-8 4236
22
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
23
Olanzapine Approved, Investigational Phase 4,Phase 3 132539-06-1 4585
24
Dextromethorphan Approved Phase 4,Phase 3,Phase 1,Phase 2 125-71-3 5360696 5362449
25
Ibuprofen Approved Phase 4,Phase 3,Phase 1,Early Phase 1 15687-27-1 3672
26
Nicotine Approved Phase 4,Phase 2,Phase 1 54-11-5 942 89594
27
Tetrabenazine Approved Phase 4,Phase 3 58-46-8 6018
28
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 1 2078-54-8 4943
29
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
30
Isoflurane Approved, Vet_approved Phase 4,Phase 1 26675-46-7 3763
31
Valproic Acid Approved, Investigational Phase 4,Phase 3,Phase 1,Early Phase 1 99-66-1 3121
32
Acetaminophen Approved Phase 4,Phase 2,Phase 3 103-90-2 1983
33
Hydrocodone Approved, Illicit Phase 4 125-29-1 5284569
34
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
35
Paroxetine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 61869-08-7 43815
36
Sertraline Approved Phase 4,Phase 2,Phase 3,Phase 1 79617-96-2 68617
37
Buprenorphine Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 52485-79-7 40400 644073
38
Methamphetamine Approved, Illicit Phase 4 537-46-2 10836
39
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-84-3 187
40
Nicergoline Approved Phase 4,Phase 3 27848-84-6 34040
41 Piracetam Approved Phase 4,Phase 3,Phase 2 7491-74-9
42
Quinidine Approved Phase 4,Phase 3,Phase 2 56-54-2 441074
43
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-41-2 439260
44
Dextroamphetamine Approved, Illicit Phase 4 51-64-9 5826
45
Aripiprazole Approved, Investigational Phase 4,Phase 3,Phase 1 129722-12-9 60795
46
Efavirenz Approved, Investigational Phase 4,Phase 2,Phase 3 154598-52-4 64139
47
Lamivudine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 134678-17-4 60825
48
Nevirapine Approved Phase 4,Phase 2,Phase 3 129618-40-2 4463
49
Zidovudine Approved Phase 4,Phase 3,Phase 2,Phase 1 30516-87-1 35370
50
Lamotrigine Approved, Investigational Phase 4,Phase 3 84057-84-1 3878

Interventional clinical trials:

(show top 50) (show all 2807)

id Name Status NCT ID Phase Drugs
1 Memantine for Agitation in Dementia Unknown status NCT00371059 Phase 4 Memantine;Placebo
2 Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment Unknown status NCT00306124 Phase 4 Levodopa
3 Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer’s Disease, Vascular Dementia, and Mixed Vascular and Alzheimer’s Dementia Unknown status NCT00229333 Phase 4 Escitalopram
4 Improving Function, Quality of Life, Glycemia in Diabetics With Dementia Unknown status NCT00792662 Phase 4 Methylphenidate;Placebo
5 The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD) Unknown status NCT00626613 Phase 4 Risperdal,reminyl
6 CALM-AD Unknown status NCT00142324 Phase 4 Donepezil
7 Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI Unknown status NCT01329601 Phase 4
8 Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia Unknown status NCT01012830 Phase 4 Huperzine A
9 Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease Unknown status NCT01849042 Phase 4 Ebixa;donepezil
10 Donepezil and Memantine in Moderate to Severe Alzheimer's Disease Unknown status NCT00866060 Phase 4 Memantine;Donepezil;Placebo donepezil;Placebo memantine
11 Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD Unknown status NCT02444637 Phase 4 Rivastigmine
12 Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:A Randomized Controlled Trial Unknown status NCT00196703 Phase 4 memantine
13 Cognitive Decline in Non-demented PD Unknown status NCT01340885 Phase 4 Strattera;Exelon
14 Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease Unknown status NCT01038050 Phase 4 Ginkgo Biloba Extract (GBE)
15 Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®) Unknown status NCT00523666 Phase 4 Galantamine (Reminyl®);Placebo/Galantamine (Reminyl®)
16 Multi-centre Clinical Trial on Hormone Replacement Treatment in China Unknown status NCT01698164 Phase 4 estradiol plus MPA;Ximingting Tablet;estradiol plus progesterone
17 Atrial Fibrillation and the Risk for Neurological Complications Unknown status NCT00357227 Phase 4
18 Controlled Trial of Deep Brain Stimulation in Early Patients With Parkinson's Disease Unknown status NCT00354133 Phase 4
19 Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes Unknown status NCT01220622 Phase 4 Nimodipine;Placebo
20 Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study Unknown status NCT01765257 Phase 4 AZILECT®;Placebo
21 Study of Memantine to Treat Huntington's Disease Unknown status NCT00652457 Phase 4 Memantine
22 Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia Completed NCT00165763 Phase 4 donepezil hydrochloride (Aricept)
23 Cilostazol Augmentation Study in Dementia Completed NCT01409564 Phase 4 Cilostazol;Placebo
24 Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT) Completed NCT00385684 Phase 4 hydrocodone/APAP w placebo PRN;hydrocodone/APAP;placebo with hydrocodone/APAP PRN
25 A Study on Behavioral and Psychological Symptoms of Dementia Completed NCT00641459 Phase 4
26 Corticolimbic Degeneration and Treatment of Dementia Completed NCT00768261 Phase 4 Memantine (Namenda®);Memantine (Namenda®);Donepezil (Aricept®)
27 Dementia Antipsychotics And Antidepressants Discontinuation Study Completed NCT00594269 Phase 4 Risperidone;Escitalopram;Citalopram;Sertraline;Paroxetine
28 Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia? Completed NCT00164970 Phase 4
29 Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia Completed NCT01585272 Phase 4 ENA713
30 Efficacy of Pain Treatment on Depression in Patients With Dementia Completed NCT02267057 Phase 4 Paracetamol;Buprenorphine;Paracetamol placebo;Buprenorphine placebo
31 The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life Completed NCT00814658 Phase 4 Galantamine;Nimodipine;Placebo
32 Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia Completed NCT00376051 Phase 4 Citalopram
33 Study on the Efficacy of Speed-Feedback Therapy for Elderly People With Dementia Completed NCT00450047 Phase 4
34 Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies Completed NCT00855686 Phase 4 Memantine;Placebo
35 Effect of Melatonin on Sleep Quality in Patients Dementia Completed NCT03066518 Phase 4 Melatonin 5 mg
36 "Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies" Completed NCT01023672 Phase 4 Armodafinil
37 Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study Completed NCT00495820 Phase 4 Methylphenidate
38 Interventional, Randomised, Double-blind, Study to Evaluate the Safety and Tolerability of Once Daily Versus Twice Daily Memantine Treatment in Patients With Dementia of Alzheimer's Type and Mini Mental State Examination (MMSE)Range 5 - 18 Completed NCT02553928 Phase 4 Memantine (once daily);Memantine (twice daily)
39 Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia Completed NCT00545974 Phase 4 memantine;Placebo pill
40 Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions Completed NCT00847860 Phase 4 Cilostazol;Aspirin
41 Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD Completed NCT00433121 Phase 4 Risperidone;Olanzapine;Haloperidole;Quetiapin;Escitalopram;Citalopram;Sertralin
42 Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP) Completed NCT00043849 Phase 4 Quetiapine
43 Prospective Research in Memory Clinics (PRIME) Completed NCT00297271 Phase 4
44 A Comparison of Two Standard Therapies in the Management of Dementia With Agitation Completed NCT00208819 Phase 4 risperidone;quetiapine;olanzapine;divalproex
45 Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's Disease Completed NCT00283725 Phase 4
46 A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia Completed NCT00947531 Phase 4 Cerebrolysin;0.9% Saline Solution
47 A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints Completed NCT00276510 Phase 4 EGb 761® (Tanakan®)
48 Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 Completed NCT00948766 Phase 4 Rivastigmine 4.6 mg/24 h (5 cm^2);Rivastigmine 9.5 mg/24 h (10 cm^2);Rivastigmine 13.3 mg/24 h (15 cm^2);Placebo
49 Donepezil to Treat Dementia in Parkinson's Disease Completed NCT00030979 Phase 4 Donepezil
50 The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia. Completed NCT00165711 Phase 4 Mecobalamin

Search NIH Clinical Center for Dementia

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Genetic Tests for Dementia

Genetic tests related to Dementia:

id Genetic test Affiliating Genes
1 Dementia 29

Anatomical Context for Dementia

MalaCards organs/tissues related to Dementia:

39
Brain, Testes, Heart, Cortex, Bone, Lung, Eye

Publications for Dementia

Articles related to Dementia:

(show top 50) (show all 5039)
id Title Authors Year
1
Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in Semantic Dementia but not with other TDP-43 pathological subtypes of Frontotemporal Lobar Degeneration. ( 28666471 )
2017
2
Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort. ( 28914354 )
2017
3
Can MRI water apparent diffusion coefficient (ADC) value discriminate between idiopathic normal pressure hydrocephalus, Alzheimer's disease and subcortical vascular dementia? ( 28923529 )
2017
4
Teaching NeuroImages: Early-onset dementia and demyelinating neuropathy disclosing cerebrotendinous xanthomatosis. ( 28894038 )
2017
5
Impact of ApoE genotypes variations on Toxoplasma patients with dementia. ( 28209315 )
2017
6
Dementia with Lewy bodies: cerebrospinal fluid suppresses neuronal network activity. ( 28953602 )
2017
7
C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. ( 28334866 )
2017
8
Corrigendum: Dementia-associated mortality and its predictors among older adults in sub-Saharan Africa: results from a 2-year follow-up in Congo (the EPIDEMCA-FU study). ( 28087559 )
2017
9
Association of dietary cholesterol and egg intakes with the risk of incident dementia or Alzheimer disease: the Kuopio Ischaemic Heart Disease Risk Factor Study. ( 28052883 )
2017
10
A new potential biomarker for dementia with Lewy bodies: Skin nerve I+-synuclein deposits. ( 28667178 )
2017
11
The association between vertebrobasilar insufficiency and the risk of dementia: a nationwide register-based retrospective cohort study in Taiwan. ( 28838901 )
2017
12
Association Between Exercise Capacity and Late Onset of Dementia, Alzheimer Disease, and Cognitive Impairment. ( 28082018 )
2017
13
Effect of glycosides of Cistanche on the expression of mitochondrial precursor protein and keratin type II cytoskeletal 6A in a rat model of vascular dementia. ( 28852399 )
2017
14
Environment as therapy: neuroscience for intellectual disability and dementia. ( 28086230 )
2017
15
Reversible Dementia with Middle Cerebellar Peduncle Hyperintensity: 1-Year Follow-Up of HIV-Negative Neurosyphilis. ( 28831790 )
2017
16
Polycystic kidney disease is significantly associated with dementia risk. ( 28855402 )
2017
17
Vascular parkinsonism and vascular dementia are associated with an increased risk of vascular events or death. ( 28905043 )
2017
18
What Works to Improve and Manage Fecal Incontinence in Care Home Residents Living With Dementia? A Realist Synthesis of the Evidence. ( 28859818 )
2017
19
White matter damage and glymphatic dysfunction in a model of vascular dementia in rats with no prior vascular pathologies. ( 27940353 )
2017
20
Semantic word category processing in semantic dementia and posterior cortical atrophy. ( 28624681 )
2017
21
An autopsied case of corticobasal degeneration presenting with frontotemporal dementia followed by myoclonus. ( 28707717 )
2017
22
Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage. ( 28318355 )
2017
23
Correlations between Gray Matter and White Matter Degeneration in Pure Alzheimer's Disease, Pure Subcortical Vascular Dementia, and Mixed Dementia. ( 28842654 )
2017
24
Anodal transcranial direct current stimulation over the right hemisphere improves auditory comprehension in a case of dementia. ( 28946572 )
2017
25
Magnesium oxide use and reduced risk of dementia: a retrospective, nationwide cohort study in Taiwan. ( 28952385 )
2017
26
Semantic dementia and the left and right temporal lobes. ( 28947063 )
2017
27
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival. ( 28631955 )
2017
28
Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. ( 28916614 )
2017
29
Serum homocysteine levels in patients with probable vascular dementia. ( 28786967 )
2017
30
Brain Network for the Core Deficits of Semantic Dementia: A Neural Network Connectivity-Behavior Mapping Study. ( 28579952 )
2017
31
Prevention of hypertension-induced vascular dementia by Lactobacillus paracasei subsp. paracasei NTU 101-fermented products. ( 27937042 )
2017
32
High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study. ( 28039523 )
2017
33
Vitamin D, Homocysteine, and Folate in Subcortical Vascular Dementia and Alzheimer Dementia. ( 28611659 )
2017
34
Effects of fisetin on hyperhomocysteinemia-induced experimental endothelial dysfunction and vascular dementia. ( 27901381 )
2017
35
Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia. ( 28826176 )
2017
36
An autopsy case of dementia with Lewy bodies clinically diagnosed to have a behavioral variant of frontotemporal dementia. ( 27737532 )
2017
37
Dementia in Parkinson's disease. ( 28088312 )
2017
38
Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia. ( 27802229 )
2017
39
Health Services Utilization in Older Adults with Dementia Receiving CareA Coordination: The MIND at Home Trial. ( 28083879 )
2017
40
Rethinking the Cognitive Mechanisms Underlying Pantomime of Tool Use: Evidence from Alzheimer's Disease and Semantic Dementia. ( 28205493 )
2017
41
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study. ( 28946566 )
2017
42
Pain, aging and dementia: Towards a biopsychosocial model. ( 28947182 )
2017
43
Prevention of Alzheimer's disease, cerebrovascular disease and dementia in women: the case for menopause hormone therapy. ( 28074678 )
2017
44
Cross-sectional and longitudinal associations of motor fluctuations and non-motor predominance with cerebrospinal I8 and AI^ as well as dementia-risk in Parkinson's disease. ( 28131192 )
2017
45
N-Terminal Prosomatostatin and Risk of Vascular Dementia. ( 28854435 )
2017
46
Effect of hippocampal La89NBP on BDNF and TrkB expression and neurological function of vascular dementia rats. ( 28944854 )
2017
47
Vitamin B6 prevents isocarbophos-induced vascular dementia in rats through N-methyl-D-aspartate receptor signaling. ( 28872356 )
2017
48
Synergistic effect of tanshinone IIA and mesenchymal stem cells on preventing learning and memory deficits via anti-apoptosis, attenuating tau phosphorylation and enhancing the activity of central cholinergic system in vascular dementia. ( 27845241 )
2017
49
Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies. ( 28088928 )
2017
50
Association of Mutations in TBK1 With Sporadic and Familial Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. ( 27892983 )
2017

Variations for Dementia

ClinVar genetic disease variations for Dementia:

6
id Gene Variation Type Significance SNP ID Assembly Location
1 PSEN1 NM_000021.3(PSEN1): c.314T> G (p.Phe105Cys) single nucleotide variant Pathogenic rs1057518919 GRCh38 Chromosome 14, 73171023: 73171023

Expression for Dementia

Search GEO for disease gene expression data for Dementia.

Pathways for Dementia

GO Terms for Dementia

Sources for Dementia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59